HomeCOYA • NASDAQ
add
Coya Therapeutics Inc
Previous close
$5.81
Day range
$5.76 - $6.00
Year range
$3.21 - $10.68
Market cap
90.72M USD
Avg Volume
49.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 3.43M | — |
Operating expense | 2.10M | 14.10% |
Net income | -2.89M | 6.58% |
Net profit margin | -84.42 | — |
Earnings per share | — | — |
EBITDA | -3.23M | -11.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 36.58M | 179.15% |
Total assets | 39.94M | 176.02% |
Total liabilities | 4.68M | 283.39% |
Total equity | 35.26M | — |
Shares outstanding | 15.22M | — |
Price to book | 2.50 | — |
Return on assets | -20.92% | — |
Return on capital | -23.92% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -2.89M | 6.58% |
Cash from operations | -4.56M | -59.13% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 5.15M | — |
Net change in cash | 585.68K | 118.20% |
Free cash flow | -3.81M | -66.69% |
About
Founded
2020
Headquarters
Website
Employees
8